| Description | 1
Day Price Change % | Market Cap | P/E | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq)  | Price
to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | -7.01 | 1751.2B | 17.39 | 14.88 | 2.58 | 0.73 | 9.58 | 12.38 | 112.16 |
| Industry: Drug Manufacturers - Major (More Info) | -8.13 | 858.6B | 14.30 | 21.30 | 4.33 | 0.56 | 8.89 | 18.30 | 106.40 |
| Companies | |||||||||
| Minrad International Inc. (BUF) | -10.91 | 48.3M | NA | -144.98 | NA | 4.72 | 5.41 | -281.41 | -3.52 |
| Evotec AG (EVTC) | -7.72 | 247.1M | NA | -30.30 | NA | 0.06 | 0.94 | -166.79 | -53.55 |
| Novogen Limited (NVGN) | -3.71 | 79.5M | NA | -56.87 | NA | NA | 3.67 | -165.01 | -31.23 |
| Quick-Med Technologies Inc. (QMDT.OB) | NA | NA | NA | NA | NA | NA | NA | -140.47 | NA |
| Oscient Pharmaceuticals Corp. (OSCI) | 4.00 | 14.8M | NA | NA | NA | NA | NA | -82.75 | -2.03 |
| CPEX Pharmaceuticals, Inc. (CPEX) | -7.46 | 36.3M | NA | NA | NA | NA | 1.69 | -42.73 | -27.97 |
| Boveran Diagnostics, Inc. (BOVD.OB) | NA | NA | NA | NA | NA | NA | NA | -13.18 | NA |
| GeoPharma Inc. (GORX) | -1.87 | 17.1M | NA | -29.09 | NA | 0.83 | 0.53 | -13.06 | 5.49 |
| Chem Rx Corporation (CHRX.OB) | NA | NA | NA | 1.79 | NA | 2.02 | NA | -0.30 | NA |
| Sanofi-Aventis (SNY) | -8.27 | 70.0B | 10.61 | 11.29 | 5.50 | 0.16 | 1.24 | 6.77 | NA |
| Aceto Corp. (ACET) | -10.60 | 160.9M | 12.12 | 10.16 | 2.70 | 0.00 | 1.15 | 7.62 | 9.83 |
| Schering-Plough Corp. (SGP) | -5.58 | 22.5B | NA | -18.30 | 1.80 | 0.83 | 2.55 | 8.86 | 53.75 |
| WuXi PharmaTech (Cayman) Inc. (WX) | -2.82 | 456.1M | 13.14 | 22.82 | NA | 0.17 | 1.47 | 12.03 | NA |
| Bristol-Myers Squibb Co. (BMY) | -5.07 | 35.5B | 16.29 | 20.03 | 6.50 | 0.73 | 3.29 | 14.68 | NA |
| Abbott Laboratories (ABT) | -9.12 | 77.5B | 18.74 | 24.38 | 2.60 | 0.73 | 4.09 | 18.07 | 122.57 |
| Eli Lilly & Co. (LLY) | -12.35 | 37.8B | 9.54 | 28.93 | 5.00 | 0.31 | 2.56 | 18.62 | 25.39 |
| Wyeth (WYE) | -5.94 | 42.6B | 9.66 | 24.92 | 3.50 | 0.58 | 2.16 | 18.87 | 36.77 |
| Johnson & Johnson (JNJ) | -7.67 | 160.9B | 13.98 | 26.46 | 3.00 | 0.30 | 3.47 | 20.23 | 122.89 |
| AstraZeneca plc (AZN) | -7.04 | 53.1B | 9.35 | 37.20 | 2.80 | 0.93 | 3.33 | 20.36 | 41.26 |
| Novartis AG (NVS) | -8.03 | 103.7B | 8.51 | 14.80 | 3.00 | 0.21 | 2.01 | 20.46 | 112.41 |
| Glaxosmithkline plc (GSK) | -9.44 | 91.3B | 11.17 | 54.40 | 5.30 | 1.84 | 7.10 | 21.89 | 103.74 |
| Pfizer Inc. (PFE) | -8.52 | 105.6B | 11.78 | 13.45 | 7.50 | 0.25 | 1.59 | 22.89 | 25.94 |
| Merck & Co. Inc. (MRK) | -8.10 | 56.2B | 11.53 | 25.00 | 5.30 | 0.25 | 2.77 | 29.22 | 118.42 |
| Spectrum Pharmaceuticals, Inc. (SPPI) | -3.88 | 31.2M | NA | -29.99 | NA | NA | 0.58 | 51.64 | 5.72 |
| American Tony Pharmaceuticals, (ATNY.OB) | NA | NA | NA | 4.62 | NA | NA | NA | NA | NA |
| AP Pharma Inc. (APPA) | -2.63 | 22.9M | NA | -84.01 | NA | NA | 1.33 | NA | -5.27 |
| Avigen Inc. (AVGN) | -12.62 | 82.5M | NA | -40.98 | NA | 0.12 | 1.46 | NA | -17.90 |
| Callisto Pharmaceuticals, Inc. (CLSP.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| HST Global, Inc. (HSTC.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| ImmunoBiotics, Inc. (IMBI.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Inhibiton Therapeutics, Inc. (IHBT.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Javelin Pharmaceuticals, Inc. (JAV) | -29.88 | 69.7M | NA | -78.54 | NA | NA | 1.60 | NA | -11.05 |
| Keryx Biopharmaceuticals Inc. (KERX) | 0.00 | 10.4M | NA | -195.25 | NA | NA | 2.00 | NA | -2.91 |
| Neurologix Inc. (NRGX.OB) | NA | NA | NA | -44.27 | NA | NA | NA | NA | NA |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | NA | NA | NA | -75.18 | NA | NA | NA | NA | NA |
| Rigel Pharmaceuticals, Inc. (RIGL) | -5.12 | 650.4M | NA | -72.84 | NA | 0.01 | 4.01 | NA | -34.43 |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Vertical Health Solutions Inc. (VHSL.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Znomics, Inc. (ZNOM.OB) | NA | NA | NA | NA | NA | NA | NA | NA | NA |